Francesco Blasi: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
m →‎top: dash
All Authority Control information is now in Wikidata, citations were updated.
Line 31: Line 31:
== Books authored ==
== Books authored ==


* Dimopoulos, Georgios., Blasi, Francesco. Textbook of Respiratory & Critical Care Infection. India: Jaypee Brothers,Medical Publishers Pvt. Limited, 2014., {{ISBN|9789350902981}}
* {{Cite book |last=Francesco |first=Blasi |url=https://www.worldcat.org/oclc/1064743478 |title=Textbook of Respiratory & Critical Care Infection. |date=2015 |publisher=Jaypee Brothers, Medical Publishers |others=Dimopoulos George |isbn=93-86107-71-6 |location=DL |oclc=1064743478}}
* {{Cite book |last=Allegra |first=L. |url=https://www.worldcat.org/oclc/882778181 |title=MALATTIE RESPIRATORIE. |date=2013 |publisher=Elsevier Health Sciences Italy |others=F. Blasi, G. W. Canonica, S. Centanni, G. Girbino |isbn=978-88-214-3305-4 |location=London |oclc=882778181}}
* Girbino, Giuseppe., Canonica, Giorgio., Centanni, Stefano., Blasi, Francesco., Allegra, Luigi. Malattie repiratorie. L'essenziale. Italy: Edra, 2013. {{ISBN|9788821433054}}
* {{Cite book |last=De Notaris |first=Enrico |url=https://www.worldcat.org/oclc/955436932 |title=Psicodrammafurtodelpensiero |date=2000 |publisher=Lettere italiane |others=Claudio Petrella, Francesco Blasi |isbn=88-7188-371-3 |location=Napoli |oclc=955436932}}
* De Notaris, Enrico., Blasi, Francesco., Petrella, Claudio. Psicodrammafurtodelpensiero. Italy: Guida, 2000. {{ISBN|9788871883717}}
* Antibiotics and the Lung. United Kingdom: European Respiratory Society Journals, 2004. {{ISBN|9781904097327}}
* {{Cite book |url=https://www.worldcat.org/oclc/56565332 |title=Antibiotics and the lung |date=2004 |publisher=European Respiratory Society Journals |others=M. Cazzola, Francesco Blasi, S. Ewig, European Respiratory Society |isbn=978-1-904097-32-7 |location=Sheffield, UK |oclc=56565332}}
* {{Cite book |url=https://www.worldcat.org/oclc/605246689 |title=Chlamydia pneumoniae infection |date=1995 |publisher=Springer |others=Luigi Allegra, F. Blasi |isbn=978-88-470-2201-0 |location=Berlin |oclc=605246689}}
* Chlamydia Pneumoniae Infection. Germany: Springer Milan, 2012. {{ISBN|9788847022010}}

== Bibliography ==
== Bibliography ==


Line 41: Line 42:


* Guidelines for the management of adult lower respiratory tract infections, 2011, https://doi.org/10.1111/j.1469-0691.2011.03672.x
* Guidelines for the management of adult lower respiratory tract infections, 2011, https://doi.org/10.1111/j.1469-0691.2011.03672.x
* {{Cite journal |last=Confalonieri |first=Marco |last2=Urbino |first2=Rosario |last3=Potena |first3=Alfredo |last4=Piattella |first4=Marco |last5=Parigi |first5=Piercarlo |last6=Puccio |first6=Giacomo |last7=Della Porta |first7=Rossana |last8=Giorgio |first8=Carbone |last9=Blasi |first9=Francesco |last10=Umberger |first10=Reba |last11=Meduri |first11=G. Umberto |date=2005-02-01 |title=Hydrocortisone Infusion for Severe Community-acquired Pneumonia |url=https://www.atsjournals.org/doi/full/10.1164/rccm.200406-808OC |journal=American Journal of Respiratory and Critical Care Medicine |volume=171 |issue=3 |pages=242–248 |doi=10.1164/rccm.200406-808OC |issn=1073-449X}}
* Hydrocortisone Infusion for Severe Community-acquired Pneumonia A Preliminary Randomized Study, 2004, https://doi.org/10.1164/rccm.200406-808OC
* {{Cite journal |last=Lönnroth |first=Knut |last2=Migliori |first2=Giovanni Battista |last3=Abubakar |first3=Ibrahim |last4=D'Ambrosio |first4=Lia |last5=Vries |first5=Gerard de |last6=Diel |first6=Roland |last7=Douglas |first7=Paul |last8=Falzon |first8=Dennis |last9=Gaudreau |first9=Marc-Andre |last10=Goletti |first10=Delia |last11=Ochoa |first11=Edilberto R. González |date=2015-04-01 |title=Towards tuberculosis elimination: an action framework for low-incidence countries |url=https://erj.ersjournals.com/content/45/4/928 |journal=European Respiratory Journal |language=en |volume=45 |issue=4 |pages=928–952 |doi=10.1183/09031936.00214014 |issn=0903-1936 |pmc=PMC4391660 |pmid=25792630}}
* Towards tuberculosis elimination: an action framework for low-incidence countries, 2015, https://doi.org/10.1183/09031936.00214014
* {{Cite journal |last=Marco |first=Fabiano Di |last2=Verga |first2=Massimo |last3=Reggente |first3=Manuela |last4=Casanova |first4=Francesca Maria |last5=Santus |first5=Pierachille |last6=Blasi |first6=Francesco |last7=Allegra |first7=Luigi |last8=Centanni |first8=Stefano |date=2006-10-01 |title=Anxiety and depression in COPD patients: The roles of gender and disease severity |url=https://www.resmedjournal.com/article/S0954-6111(06)00060-6/abstract |journal=Respiratory Medicine |language=English |volume=100 |issue=10 |pages=1767–1774 |doi=10.1016/j.rmed.2006.01.026 |issn=0954-6111 |pmid=16531031}}
* Anxiety and depression in COPD patients: The roles of gender and disease severity, 2006, https://doi.org/10.1016/j.rmed.2006.01.026
* Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes, 1985, https://doi.org/10.1073/pnas.82.15.4939
* {{Cite journal |last=Stoppelli |first=M P |last2=Corti |first2=A |last3=Soffientini |first3=A |last4=Cassani |first4=G |last5=Blasi |first5=F |last6=Assoian |first6=R K |date=1985 |title=Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. |url=http://dx.doi.org/10.1073/pnas.82.15.4939 |journal=Proceedings of the National Academy of Sciences |volume=82 |issue=15 |pages=4939–4943 |doi=10.1073/pnas.82.15.4939 |issn=0027-8424 |pmc=PMC390473 |pmid=2991901}}
* Risk factors for community-acquired pneumonia in adults in Europe: a literature review, http://dx.doi.org/10.1136/thoraxjnl-2013-204282
* {{Cite journal |last=Torres |first=Antoni |last2=Peetermans |first2=Willy E. |last3=Viegi |first3=Giovanni |last4=Blasi |first4=Francesco |date=2013-11-01 |title=Risk factors for community-acquired pneumonia in adults in Europe: a literature review |url=https://thorax.bmj.com/content/68/11/1057 |journal=Thorax |language=en |volume=68 |issue=11 |pages=1057–1065 |doi=10.1136/thoraxjnl-2013-204282 |issn=0040-6376 |pmc=PMC3812874 |pmid=24130229}}
* {{Cite journal |last=Polverino |first=Eva |last2=Goeminne |first2=Pieter C. |last3=McDonnell |first3=Melissa J. |last4=Aliberti |first4=Stefano |last5=Marshall |first5=Sara E. |last6=Loebinger |first6=Michael R. |last7=Murris |first7=Marlene |last8=Cantón |first8=Rafael |last9=Torres |first9=Antoni |last10=Dimakou |first10=Katerina |last11=Soyza |first11=Anthony De |date=2017-09-01 |title=European Respiratory Society guidelines for the management of adult bronchiectasis |url=https://erj.ersjournals.com/content/50/3/1700629 |journal=European Respiratory Journal |language=en |volume=50 |issue=3 |doi=10.1183/13993003.00629-2017 |issn=0903-1936 |pmid=28889110}}
* European Respiratory Society guidelines for the management of adult bronchiectasis, 2017, https://doi.org/10.1183/13993003.00629-2017
* {{Cite journal |last=Sozzi |first=Fabiola B. |last2=Belmonte |first2=Marta |last3=Schiavone |first3=Marco |last4=Canetta |first4=Ciro |last5=Blasi |first5=Francesco |date=2020 |title=Considerations on cardiac patients during Covid‐19 outbreak |url=https://onlinelibrary.wiley.com/doi/10.1111/echo.14790 |journal=Echocardiography |language=en |volume=37 |issue=8 |pages=1321–1322 |doi=10.1111/echo.14790 |issn=0742-2822 |pmc=PMC7404830 |pmid=32654172}}
* Considerations on cardiac patients during Covid-19 outbreak, July 2020, https://doi.org/10.1111/echo.14790
* Genomewide Association Study of Severe Covid-19 with Respiratory Failure, https://doi.org/10.1056/NEJMoa2020283
* {{Cite journal |last=Group |first=The Severe Covid-19 GWAS |date=2020-06-17 |title=Genomewide Association Study of Severe Covid-19 with Respiratory Failure |url=https://www.nejm.org/doi/10.1056/NEJMoa2020283 |journal=New England Journal of Medicine |language=en |doi=10.1056/NEJMoa2020283 |pmc=PMC7315890 |pmid=32558485}}
* Future directions for the ERS: Presidential plans, https://doi.org/10.1183/09031936.00114513
* {{Cite journal |last=Blasi |first=Francesco |last2=Barnes |first2=Peter J. |last3=Gaga |first3=Mina |last4=Migliori |first4=Giovanni Battista |date=2013-10-01 |title=Future directions for the ERS: Presidential plans |url=https://erj.ersjournals.com/content/42/4/875 |journal=European Respiratory Journal |language=en |volume=42 |issue=4 |pages=875–880 |doi=10.1183/09031936.00114513 |issn=0903-1936 |pmid=24081751}}
* Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry, https://doi.org/10.2147/JAA.S274245
* {{Cite journal |last=Puggioni |first=Francesca |last2=Brussino |first2=Luisa |last3=Canonica |first3=Giorgio Walter |last4=Blasi |first4=Francesco |last5=Paggiaro |first5=Pierluigi |last6=Caminati |first6=Marco |last7=Latorre |first7=Manuela |last8=Heffler |first8=Enrico |last9=Senna |first9=Gianenrico |date=2020-11-10 |title=Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry |url=https://www.dovepress.com/frequency-of-tiotropium-bromide-use-and-clinical-features-of-patients--peer-reviewed-fulltext-article-JAA |journal=Journal of Asthma and Allergy |language=English |volume=13 |pages=599–604 |doi=10.2147/JAA.S274245 |pmc=PMC7667506 |pmid=33204116}}


=== Additional sources ===
=== Additional sources ===
Line 73: Line 74:
* [https://www.scopus.com/authid/detail.uri?authorId=57211284402 Francesco Blasi] in [[Scopus]]
* [https://www.scopus.com/authid/detail.uri?authorId=57211284402 Francesco Blasi] in [[Scopus]]


{{Authority control}}
{|
|{{Authority control|ISNI=0000000120272714|VIAF=64160866|ORCID=0000000222859970|SCOPUS=57211284402}}
|}


{{DEFAULTSORT:Blasi, Francesco}}
{{DEFAULTSORT:Blasi, Francesco}}

Revision as of 09:50, 27 April 2022

Francesco Blasi
Francesco Blasi
Born(1959-11-18)November 18, 1959
CitizenshipItalian
EducationUniversity of Milan
Alma materUniversity of Milan
Scientific career
InstitutionsUniversity of Milan
European Registry of Bronchiectasis
European Respiratory Society
Italian Respiratory Society


Francesco Blasi (born 18 November, 1959) is an Italian Medical scientist and professor. His domain of research is respiratory medicine. He has been the president of European Respiratory Society (ERS) during 2012–13.[1] He has served as the president of Italian Respiratory Society during 2015–17. He is presently serving as one of the board of directors of University of Milan and is the professor of respiratory medicine in department pathophysiology and transplantation in University of Milan.[2][3]

Early life and education

Blasi received the MD degree from University of Milan in 1984. He carried out specialization in Cardiology and Respiratory Diseases from the same University during 1987 and 1997 respectively. He carried out his PhD in Respiratory Diseases from the University of Milan in 1991.[4]

Research area

Blasi is known for his work in the domain of immunology, bronchitis, pneumonia, cystic fibrosis, COPD, tuberculosis, lung transplantation etc.[5] His research area includes the effects of atypical bacterial infection in the immunity at cellular level in the chronic case of bronchitis.[6] He also known for working on the effects of antibiotics on Chronic obstructive pulmonary disease (COPD) and the for finding the roles of viral infection and atypical bacteria in the case of asthma onset.[7]

Associations

Blasi has been nominated as the chair of scientific committee of World Bronchiectasis Conference in 2017.[8] He has been the founder member of European Registry of Bronchiectasis (EMBARC), Italian Bronchiectasis Registry (IRIDE) and Italian NTM Registry.[9][10] He has served as head of cardiothoratic unit (IRCCS) at Policlinico of Milan.[11] He has been the vice-president of European Respiratory Society (ERS) till 2011 and served as president during 2012–13.[12] He has served as the president of Italian Respiratory Society during 2015–17.[13] Besides being the professor of respiratory medicine, he is also a board of directors of University of Milan.[14]

Books authored

  • Francesco, Blasi (2015). Textbook of Respiratory & Critical Care Infection. Dimopoulos George. DL: Jaypee Brothers, Medical Publishers. ISBN 93-86107-71-6. OCLC 1064743478.
  • Allegra, L. (2013). MALATTIE RESPIRATORIE. F. Blasi, G. W. Canonica, S. Centanni, G. Girbino. London: Elsevier Health Sciences Italy. ISBN 978-88-214-3305-4. OCLC 882778181.
  • De Notaris, Enrico (2000). Psicodrammafurtodelpensiero. Claudio Petrella, Francesco Blasi. Napoli: Lettere italiane. ISBN 88-7188-371-3. OCLC 955436932.
  • Antibiotics and the lung. M. Cazzola, Francesco Blasi, S. Ewig, European Respiratory Society. Sheffield, UK: European Respiratory Society Journals. 2004. ISBN 978-1-904097-32-7. OCLC 56565332.{{cite book}}: CS1 maint: others (link)
  • Chlamydia pneumoniae infection. Luigi Allegra, F. Blasi. Berlin: Springer. 1995. ISBN 978-88-470-2201-0. OCLC 605246689.{{cite book}}: CS1 maint: others (link)

Bibliography

Notable publications

Additional sources

  • Annesi-Maesano, Isabella. Respiratory Epidemiology. United Kingdom: European Respiratory Society, 2014.
  • Blasi, Francesco B.. Lung Diseases: Chronic Respiratory Infections. Switzerland: MDPI AG, 2018.
  • Bronchiectasis. United Kingdom: European Respiratory Society, 2018.
  • Palange, Paolo., Rohde, Gernot. ERS Handbook of Respiratory Medicine. United Kingdom: European Respiratory Society, 2019.
  • Vijayan, Vannan K., Jindal, Surinder K. World Clinics: Pulmonary & Critical Care Medicine - Chronic Obstructive Pulmonary Disease. India: Jaypee Brothers,Medical Publishers Pvt. Limited, 2013.
  • Woodhead, Mark., Torres, Antoni., Mandell, Lionel., Ewig, Santiago. Respiratory Infections. United Kingdom: CRC Press, 2006.
  • Menendez, Rosario. Community-Acquired Pneumonia: Strategies for Management. Germany: Wiley, 2008.
  • Leeper, Kenneth V.. Severe Community Acquired Pneumonia. Germany: Springer US, 2013.
  • Webb, Andrew. Oxford Textbook of Critical Care. United Kingdom: Oxford University Press, 2016.

References

  1. ^ "Lung diseases cause one in 10 deaths across Europe". BBC News. 2013-09-05. Retrieved 2020-11-21.
  2. ^ "Seguire le terapie: così si controllano le broncopatie anche in epoca Covid". L'Unione Sarda.it (in Italian). 2020-06-29. Retrieved 2020-11-21.
  3. ^ "Blasi Francesco Bruno Arturo | Università degli Studi di Milano Statale". www.unimi.it. Retrieved 2020-11-21.
  4. ^ "Francesco Blasi".{{cite web}}: CS1 maint: url-status (link)
  5. ^ "WAidid – World Association for Infectious Diseases and Immunological Disorders". waidid.org (in Italian). Retrieved 2020-11-21.
  6. ^ "Speakers | Lung Health 2017". www.lung-health.org. Retrieved 2020-11-21.
  7. ^ Blasi, Francesco; Miravitlles, Marc (June 2013). The Spectrum of Bronchial Infection: European Respiratory Monograph. European Respiratory Society. ISBN 978-1-84984-035-4.
  8. ^ "Scientific Committee". 2nd World Bronchiectasis Conference. Retrieved 2020-11-21.
  9. ^ "EMBARC - EMBARC Committee". www.bronchiectasis.eu. Retrieved 2020-11-21.
  10. ^ "Faculty – Lung health 2019". Retrieved 2020-11-21.
  11. ^ "Francesco Blasi - Professor of Asthma Clinical Immunology, Cardiothoracic Surgery, Clinical Psychology, Pathology in Milano, Lombardia, Italy | eMedEvents". www.emedevents.com. Retrieved 2020-11-21.
  12. ^ "Meeting with the European Respiratory Society". www.euro.who.int. Retrieved 2020-11-24.
  13. ^ "Malattie respiratorie, studio boccia antibiotici"Utili solo se c'è il rischio di polmonite"". la Repubblica (in Italian). 2013-02-15. Retrieved 2020-11-24.
  14. ^ "Board of Directors | Università degli Studi di Milano Statale". www.unimi.it. Retrieved 2020-11-24.

External links